Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? (Q43507724)
Jump to navigation
Jump to search
scientific article published in January 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? |
scientific article published in January 2001 |
Statements
1 reference
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? (English)
1 reference
1 reference
P Greengard
1 reference
E M Mandelkow
1 reference
S Leclerc
1 reference
R Hoessel
1 reference
J A Bibb
1 reference
G L Snyder
1 reference
J Biernat
1 reference
Y Z Wu
1 reference
G Eisenbrand
1 reference
L Meijer
1 reference
1 January 2001
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference